is bayer a good stock to buy?
The company's revenue and earnings growth for the past few years has been slow, and that trend looks set to continue. When factoring in the potential adverse impact of the COVID-19 pandemic, Bayer looks even less like a buy, even taking into account its attractive valuation metrics.